High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin

Lack of effective biomarkers is one of the challenges in current neoadjuvant chemotherapy to predict drug response and sensitivity of cervical squamous cell carcinoma (CSCC). The present study was designed to investigate the correlation of the expression of survivin, an inhibitor of apoptosis with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yunzhong, Yan, Hong, Li, Ruiping, Guo, Yuzhen, Zheng, Rongfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531053/
https://www.ncbi.nlm.nih.gov/pubmed/31096466
http://dx.doi.org/10.1097/MD.0000000000015607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531053/
https://www.ncbi.nlm.nih.gov/pubmed/31096466
http://dx.doi.org/10.1097/MD.0000000000015607

Ejemplares similares